Skip to main content
European Commission logo print header
Contenuto archiviato il 2024-04-19

Identification of malaria vaccine candidates by passive transfer in infected individuals of antibodies with defined specificities

Obiettivo



GENERAL AND LONGTERM OBJECTIVES:
1-IDENTIFY THE TARGET ANTIGENS OF ACQUIRED IMMUNITY("PREMUNITION") FOR VACCINATION PURPOSES.
2-PRODUCE THERAPEUTIC ANTIBODIES BY DNA RECOMBINANT TECHNIQUES. SPECIFIC OBJECTIVES.
1-ISOLATE ANTIBODIES WITH WRLL-DEFINED SPECIFICITIES BY AFFINITY-PURIFICATION OF HUMAN IMMUNE IgG ON RELEVANT PEPTIDES AND ASSESS THEIR IN VIVO EFFICIENCY BY PASSIVE TRANSFER IN RECRUDESCENT ASYMTOMATICP.FALCIPARUM CASES.
2-DEVELOP THE TECHNOLOGY OF RECOMBINANT HUMAN ANTIBODIES SPECIFIC OF PF. ANTIGENS AS A MEANS TO PRODUCE LARGE AMOUNTS OF THE SAME ANTIBODY SPECIFICITIES WHICH MAY PROVE TO BE EFFECTIVE BY PASSIVE TRANSFER(OBJ.1) AND WHICH COULD BE USED FOR CLINICAL TREATMENT.
3-FURTHER EPIDEMIOLOGICAL STUDIES BY MEANS OF IN-VITRO CELL-ANTIBIDY COOPERATION ASSAYS(ADCI)IN ORDER:i)TO CONFIRM THE RELEVANCE OF THE TARGET ANTIGENS ALREADY SELECTED,IDENTIFY CROSS-REACTIVE EPITOPES,IF ANY,AND ii)TO DEFINE IF THERE ARE OTHER ANTIGENS TARGETTED BY DEFENSE MECHANISMS.

Argomento(i)

Data not available

Invito a presentare proposte

Data not available

Meccanismo di finanziamento

CSC - Cost-sharing contracts

Coordinatore

INSTITUT PASTEUR
Contributo UE
Nessun dato
Indirizzo
Rue du Docteur Roux 28
75724 PARIS
Francia

Mostra sulla mappa

Costo totale
Nessun dato

Partecipanti (3)